Surgical Revascularization of Chronically Occluded Coronary Arteries—What You See Is What You Get?
26 November 2018
23 April 2019
09 June 2019 (online)
Background Revascularization strategy in coronary artery bypass grafting (CABG) surgery usually depends on coronary dimension and stenosis severity. Little is known about the relation of preoperative evaluation of scarcely or invisibly chronic occluded coronary arteries (chronic total occlusion [CTO]) and revascularization rate or anastomosis quality. We aimed to evaluate the success rates of CTO revascularization in CABG surgery and determine the influence of coronary lumen visibility and collateralization in preoperative angiograms on revascularization rates, bypass blood flow, and target vessel diameter.
Method Preoperative coronary angiograms were evaluated for 938 consecutive patients who underwent isolated CABG surgery between 2014 and 2016 and screened for occluded coronary arteries. The occluded vessels were scored for visibility using the Rentrop grading of collateral filling. Intraoperatively, dimensions of the occluded arteries were measured using conventional vessel probes, and anastomosis quality was assessed by transit time flow measurement.
Results A total of 404 (43.1%) patients were identified with at least one CTO. Revascularization rates differed from 96.2% in the left anterior descending artery, to 85.0% in left circumflex artery-dependent vessels, and 78.8% in right coronary artery territory. Coronary visibility and grade of collateralization in the preoperative angiogram had no influence on intraoperatively measured coronary diameter. Bypass blood flow in grafts revascularizing CTOs lacking collateralization were not significantly lower than those grafts leading to CTOs with higher Rentrop scores.
Conclusion Preoperative coronary assessment often differs from intraoperative findings. Our study confirms that even patients with scarcely collateralized CTOs and impaired visibility in the coronary angiogram have a high chance of complete revascularization during CABG surgery.
Keywordschronic total occlusion - CTO - complete revascularization - CABG - surgical revascularization
* Both authors contributed equally to the manuscript.
- 1 Kahn JK. Angiographic suitability for catheter revascularization of total coronary occlusions in patients from a community hospital setting. Am Heart J 1993; 126 (3 Pt 1): 561-564
- 2 Fefer P, Knudtson ML, Cheema AN. , et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol 2012; 59 (11) 991-997
- 3 Råmunddal T, Hoebers LP, Henriques JPS. , et al. Chronic total occlusions in Sweden--a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). PLoS One 2014; 9 (08) e103850
- 4 Tomasello SD, Boukhris M, Giubilato S. , et al. Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. Eur Heart J 2015; 36 (45) 3189-3198
- 5 Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5 (03) 587-592
- 6 Vo MN, Brilakis ES, Kass M, Ravandi A. Physiologic significance of coronary collaterals in chronic total occlusions. Can J Physiol Pharmacol 2015; 93 (10) 867-871
- 7 Luo C, Huang M, Li J. , et al. Predictors of interventional success of antegrade PCI for CTO. JACC Cardiovasc Imaging 2015; 8 (07) 804-813
- 8 Werner GS, Surber R, Ferrari M, Fritzenwanger M, Figulla HR. The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction. Eur Heart J 2006; 27 (20) 2406-2412
- 9 Jang WJ, Yang JH, Choi SH. , et al. Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well-developed collateral circulation. JACC Cardiovasc Interv 2015; 8 (02) 271-279
- 10 Nombela-Franco L, Mitroi CD, Fernández-Lozano I. , et al. Ventricular arrhythmias among implantable cardioverter-defibrillator recipients for primary prevention: impact of chronic total coronary occlusion (VACTO Primary Study). Circ Arrhythmia Electrophysiol 2012; 5 (01) 147-54
- 11 Claessen BEPM, van der Schaaf RJ, Verouden NJ. , et al. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention. JACC Cardiovasc Interv 2009; 2 (11) 1128-1134
- 12 Gershlick AH, Khan JN, Kelly DJ. , et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol 2015; 65 (10) 963-972
- 13 Chang M, Ahn JM, Kim N. , et al. Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents. Am Heart J 2016; 179: 157-165
- 14 Garcia S, Sandoval Y, Roukoz H. , et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol 2013; 62 (16) 1421-1431
- 15 Strauss BH, Shuvy M, Wijeysundera HC. Revascularization of chronic total occlusions: time to reconsider?. J Am Coll Cardiol 2014; 64 (12) 1281-1289
- 16 Kappetein AP, Dawkins KD, Mohr FW. , et al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg 2006; 29 (04) 486-491
- 17 Farooq V, van Klaveren D, Steyerberg EW. , et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013; 381 (9867): 639-650
- 18 Toth GG, De Bruyne B, Kala P. , et al. Study design of the Graft Patency After FFR-Guided Versus Angiography-Guided CABG Trial (GRAFFITI). J Cardiovasc Transl Res 2018; 11 (04) 269-273
- 19 Garcia S, Sandoval Y, Roukoz H. , et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol 2013; 62 (16) 1421-1431
- 20 Hannan EL, Racz M, Holmes DR. , et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 2006; 113 (20) 2406-2412
- 21 Oshima H, Tokuda Y, Araki Y. , et al. Predictors of early graft failure after coronary artery bypass grafting for chronic total occlusion. Interact Cardiovasc Thorac Surg 2016; 23 (01) 142-149
- 22 Borowski A, Godehardt E, Dalyanoglu H. Surgical decision making for revascularization of chronically occluded right coronary artery. Gen Thorac Cardiovasc Surg 2017; 65 (01) 17-24
- 23 Tsai TT, Stanislawski MA, Shunk KA. , et al. Contemporary incidence, management, and long-term outcomes of percutaneous coronary interventions for chronic coronary artery otal occlusions: insights from the VA CART Program. JACC Cardiovasc Interv 2017; 10 (09) 866-875
- 24 Azzalini L, Torregrossa G, Puskas JD. , et al. Percutaneous revascularization of chronic total occlusions: rationale, indications, techniques, and the cardiac surgeon's point of view. Int J Cardiol 2017; 231: 90-96
- 25 Wang L, Lu MJ, Feng L. , et al. Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion. J Nucl Cardiol 2018
- 26 Elias J, van Dongen IM, Hoebers LP. , et al; EXPLORE investigators. Improved recovery of regional left ventricular function after PCI of chronic total occlusion in STEMI patients: a cardiovascular magnetic resonance study of the randomized controlled EXPLORE trial. J Cardiovasc Magn Reson 2017; 19 (01) 53